SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
425	Filing of certain prospectuses and communications in connection with business combination transactions	May 29, 2009	View HTML 0001047469-09-006057.pdf 0001047469-09-006057.rtf 0001047469-09-006057.xls
8-K	Report of unscheduled material events or corporate event	May 29, 2009	View HTML 0001047469-09-006056.pdf 0001047469-09-006056.rtf 0001047469-09-006056.xls
SC 13G	A statement of beneficial ownership of common stock by certain persons	May 27, 2009	View HTML 0000950123-09-009530.pdf 0000950123-09-009530.rtf 0000950123-09-009530.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 8, 2009	View HTML 0001104659-09-030896.pdf 0001104659-09-030896.rtf 0001104659-09-030896.xls
8-K	Report of unscheduled material events or corporate event	May 5, 2009	View HTML 0001157523-09-003391.pdf 0001157523-09-003391.rtf 0001157523-09-003391.xls
CT ORDER	CT ORDER	Mar 12, 2009	View HTML 9999999997-09-006977.pdf
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 5, 2009	View HTML 0001047469-09-002264.pdf 0001047469-09-002264.rtf 0001047469-09-002264.xls
8-K	Report of unscheduled material events or corporate event	Feb 27, 2009	View HTML 0001157523-09-001702.pdf 0001157523-09-001702.rtf 0001157523-09-001702.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 12, 2009	View HTML 0001193125-09-026737.pdf 0001193125-09-026737.rtf 0001193125-09-026737.xls
8-K	Report of unscheduled material events or corporate event	Feb 5, 2009	View HTML 0001104659-09-006860.pdf 0001104659-09-006860.rtf 0001104659-09-006860.xls

Data provided by Kaleidoscope.